Semi-Annual Consolidated Statement Of Cash Flows

Fuji Pharma Co.,Ltd. - Filing #7712320

Concept 2018-10-01 to
2019-03-31
As at
2019-03-31
As at
2018-09-30
As at
2018-03-31
2017-10-01 to
2018-03-31
As at
2017-09-30
Semi-annual consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
2,495,000,000 JPY
2,644,000,000 JPY
Interest and dividends received
2,000,000 JPY
1,000,000 JPY
Interest paid
-23,000,000 JPY
-32,000,000 JPY
Income taxes paid
-308,000,000 JPY
-911,000,000 JPY
Net cash provided by (used in) operating activities
2,281,000,000 JPY
1,702,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-783,000,000 JPY
-662,000,000 JPY
Proceeds from sale of property, plant and equipment
1,000,000 JPY
1,272,000,000 JPY
Purchase of investment securities
-5,548,000,000 JPY
JPY
Other, net
0 JPY
0 JPY
Net cash provided by (used in) investing activities
-8,150,000,000 JPY
-233,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
7,000,000,000 JPY
JPY
Repayments of long-term borrowings
-210,000,000 JPY
-653,000,000 JPY
Purchase of treasury shares
JPY
-40,000,000 JPY
Dividends paid
-419,000,000 JPY
-374,000,000 JPY
Net cash provided by (used in) financing activities
6,068,000,000 JPY
-1,332,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
-15,000,000 JPY
-15,000,000 JPY
Net increase (decrease) in cash and cash equivalents
183,000,000 JPY
121,000,000 JPY
Cash and cash equivalents
6,435,000,000 JPY
6,251,000,000 JPY
5,624,000,000 JPY
5,503,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.